442 related articles for article (PubMed ID: 20077322)
21. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
Morin K; Morse LJ
Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
[No Abstract] [Full Text] [Related]
22. Industry relations with emergency medicine graduate medical education programs.
Kowalenko T; Char D; Marco C; Asher S; Raja A; Farrell S; Sokolove PE;
Acad Emerg Med; 2009 Oct; 16(10):1025-30. PubMed ID: 19799581
[TBL] [Abstract][Full Text] [Related]
23. Public disclosure of conflicts of interest: moving the policy debate forward.
Campbell EG
Arch Intern Med; 2010 Apr; 170(8):667. PubMed ID: 20421548
[No Abstract] [Full Text] [Related]
24. Doctors and the drug industry: reader feedback.
Nardone DA
Am J Med; 2005 Oct; 118(10):1176-7; author reply 1177. PubMed ID: 16194658
[No Abstract] [Full Text] [Related]
25. Icebreakers-unexpected outcomes.
Jamshed SQ; Mohamed Ibrahim MI; Hassali MA
J Coll Physicians Surg Pak; 2010 Feb; 20(2):142. PubMed ID: 20378048
[No Abstract] [Full Text] [Related]
26. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
27. Doctors and drug companies.
Lambert LA
N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
[No Abstract] [Full Text] [Related]
28. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
[TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts.
Berger JT
Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495
[No Abstract] [Full Text] [Related]
30. The gift of drug samples.
Reid EE
Hastings Cent Rep; 2012; 42(2):49. PubMed ID: 22733332
[No Abstract] [Full Text] [Related]
31. Managing conflicts of interest and commitment: academic medicine and the physician's progress.
Kachuck NJ
J Med Ethics; 2011 Jan; 37(1):2-5. PubMed ID: 21149321
[No Abstract] [Full Text] [Related]
32. Your soul for a pen?
DeMaria AN
J Am Coll Cardiol; 2007 Mar; 49(11):1220-2. PubMed ID: 17367667
[No Abstract] [Full Text] [Related]
33. The medical profession and the pharmaceutical industry: when will we open our eyes?
Breen KJ
Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
[TBL] [Abstract][Full Text] [Related]
34. Lunch with Lilly: who pays?
Strong C
Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
[No Abstract] [Full Text] [Related]
35. Academic medical centers and conflicts of interest.
Watson PY; Musial JL; Khandewal AK; Buckley JD
JAMA; 2006 Jun; 295(24):2847-8; author reply 2848-9. PubMed ID: 16804147
[No Abstract] [Full Text] [Related]
36. Drug reps and the academic medical center: a case for management rather than prohibition.
Huddle TS
Perspect Biol Med; 2008; 51(2):251-60. PubMed ID: 18453729
[TBL] [Abstract][Full Text] [Related]
37. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
Katz D; Caplan AL; Merz JF
Am J Bioeth; 2003; 3(3):39-46. PubMed ID: 14594489
[TBL] [Abstract][Full Text] [Related]
38. The high cost of free lunch.
Rankin RC
Obstet Gynecol; 2007 Oct; 110(4):932. PubMed ID: 17906040
[No Abstract] [Full Text] [Related]
39. The high cost of free lunch.
Randall DA
Obstet Gynecol; 2007 Oct; 110(4):932; author reply 932-3. PubMed ID: 17906039
[No Abstract] [Full Text] [Related]
40. The high cost of free lunch.
Frohlich EP
Obstet Gynecol; 2007 Oct; 110(4):931; author reply 932-3. PubMed ID: 17906038
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
